Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro

British Journal of Pharmacology

Volumn 136, Issue 8, 2002, Pages 1178-1184

  Siniscalchi, Anna ^a   Rodi, Donata ^a   Morari, Michele ^a   Marti, Matteo ^a   Cavallini, Sabrina ^a   Marino, Silvia ^a   Beani, Lorenzo ^a   Bianchi, Clementina ^a  

^a Section of Pharmacology   (Italy)

Author keywords

GABA; Naloxone; Nociceptin orphanin FQ; Noradrenaline release; Rodent cerebral cortex; Slices; Species differences; Synaptosomes

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BICUCULLINE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; MU OPIATE RECEPTOR; NALOXONE; NOCICEPTIN; NOCICEPTIN DERIVATIVE; NOCICEPTIN RECEPTOR ANTAGONIST; NOCICEPTIN[1-13][1 NORPHENYLALANINE]; NORADRENALIN; NORBINALTORPHIMINE; POTASSIUM CHLORIDE; UNCLASSIFIED DRUG; EXCITATORY AMINO ACID; NARCOTIC ANTAGONIST; NOCICEPTIN RECEPTOR; OPIATE PEPTIDE; OPIATE RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEPTH STIMULATION; BRAIN SLICE; BRAIN SYNAPTOSOME; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; ELECTROSTIMULATION; GUINEA PIG; IN VITRO STUDY; MALE; MOUSE; NEUROMODULATION; NONHUMAN; NORADRENALIN RELEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE; ANALYSIS OF VARIANCE; ANIMAL; COMPARATIVE STUDY; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SYNAPTOSOME; ULTRASTRUCTURE;

ANALYSIS OF VARIANCE; ANIMALS; CEREBRAL CORTEX; ELECTRIC STIMULATION; EXCITATORY AMINO ACIDS; GUINEA PIGS; MALE; MICE; NARCOTIC ANTAGONISTS; NOREPINEPHRINE; OPIOID PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RECEPTORS, OPIOID; RECEPTORS, OPIOID, MU; SPECIES SPECIFICITY; SYNAPTOSOMES;

EID: 0036686733     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704841     Document Type: Article

References (47)

1. Inhibitory action of nociceptin/orphanin FQ on functionally different thalamic neurons in urethane-anaesthetized rats
2. Regulation of the release of coexisting neurotransmitters
3. Noradrenaline inhibition of acetylcholine release from guinea pig brain
4. Different approaches to study acetylcholine release: Endogenous ACh versus tritium efflux
5. 7 binding to multiple sites in rat and guinea pig cerebellum
6. Effects of nociceptin and endomorphin I on the electrically stimulated human vas deferens
7. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type
8. 2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist
9. 2, a new selective nociceptin receptor antagonist
10. Pharmacology of nociceptin and its receptor: A novel therapeutic target
11. Opioid receptors
12. GABA induces norepinephrine exocytosis from hippocampal noradrenergic axon terminals by a dual mechanism involving different voltage-sensitive calcium channels
13. 3H-norepinephrine release in hypothalamic, preoptic area and cortical slices of female rats
14. Evidence that GABA augmentation of norepinephrine release is mediated by interneurons
15. Modulation of enkephalin release by nociceptin (orphanin FQ)
16. Nociceptin and neurotransmitter release in the periphery
17. Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin(1-13)-peptide amide
18. A new selective antagonist of the nociceptin receptor
19. Receptor subtypes or species homologues: Relevance to drug discovery
20. Opiate modulating properties of nociceptin/orphanin FQ
21. Cellular actions of nociceptin: Transduction mechanisms
22. The orphan opioid receptor and its endogenous ligand nociceptin/orphanin FQ
23. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress
24. International Union of Pharmacology Committee on receptor nomenclature and drug classification. IX. Recommendations on terms and symbols in quantitative pharmacology
25. Modification of dopamine release by nociceptin in conscious rat striatum
26. Oligomerization of opioid receptors: Generation of novel signaling units
27. + currents in hippocampal CA1 neurons by both ORL-1 and opiate receptor mechanisms
28. The potential therapeutic value of nociceptin receptor agonists and antagonists
29. 1 receptor
30. The molecular and behavioural pharmacology of the orphanin FQ/nociceptin peptide and receptor family
31. 1, a novel member of the opioid receptor family. Cloning, functional expression and localization
32. 2+ channel inhibition and its desensitisation in NG108-15 cells
33. 2 on rat brain noradrenaline release in vivo and in vitro
34. 1) receptors to adenylyl cyclase in the different layers of the rat main olfactory bulb
35. Orphanin FQ, agonist of the orphan opioid receptor ORL1, stimulates feeding in rats
36. B autoreceptors
37. Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor
38. Naloxone sensitive orphanin FQ-induced analgesia in mice
39. Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin
40. Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system
41. 1 receptors
42. Beta-endorphin: A highly selective endogenous opioid agonist for presynaptic mu opioid receptors
43. 3H]-5-HT release from rat cerebral cortex slices
44. Species difference in nociceptin inhibition of cortical noradrenaline release in vitro
45. How opioids inhibit GABA-mediated neurotransmission
46. 1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro
47. Species difference in mu- and delta-opioid receptors